Literature DB >> 36118542

How We Do It: Whole Lung Lavage.

Deepa Shrestha1, Sahajal Dhooria2, Ganesh Kumar Munirathinam1, Inderpaul Singh Sehgal1, Kuruswamy Thurai Prasad1, Babu Ram3, Harkant Singh1, Ashutosh N Aggarwal2, Goverdhan D Puri1, Valliappan Muthu1, Ritesh Agarwal1,2,3.   

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare pulmonary disorder characterized by the accumulation of surfactant in the alveolar spaces resulting in hypoxemic respiratory failure. Whole lung lavage (WLL), the preferred treatment for PAP, physically removes the lipoproteinaceous material from the alveolar spaces. Since its initial description in 1963, the WLL procedure has undergone various modifications. However, the procedure has not been standardized yet. After securing a double lumen endotracheal tube, we perform WLL under general anesthesia. One lung is ventilated, while the other is lavaged using one-liter aliquots of pre-warmed saline. We use gravity-assisted drainage of the lavaged lung after each cycle till the milky white and opaque fluid becomes clear (usually 15-20 cycles). Herein, we describe the step-by-step procedure, precautions, and monitoring of WLL. We also provide videos demonstrating one-lung ventilation and bronchoscopic confirmation of lung isolation.

Entities:  

Keywords:  Pulmonary alveolar proteinosis; bronchoalveolar lavage; bronchoscopy; interstitial lung disease: diffuse parenchymal lung disease

Year:  2022        PMID: 36118542      PMCID: PMC9437756          DOI: 10.36141/svdld.v39i2.12884

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   1.803


  41 in total

1.  Bronchopulmonary lavage in man.

Authors:  J Ramirez; R F Kieffer; W C Ball
Journal:  Ann Intern Med       Date:  1965-11       Impact factor: 25.391

Review 2.  Pulmonary alveolar proteinosis.

Authors:  Bruce C Trapnell; Koh Nakata; Francesco Bonella; Ilaria Campo; Matthias Griese; John Hamilton; Tisha Wang; Cliff Morgan; Vincent Cottin; Cormac McCarthy
Journal:  Nat Rev Dis Primers       Date:  2019-03-07       Impact factor: 52.329

3.  Whole-lung lavage for pulmonary alveolar proteinosis.

Authors:  Gaëtane Michaud; Chakravarthy Reddy; Armin Ernst
Journal:  Chest       Date:  2009-12       Impact factor: 9.410

4.  Bilateral whole lung lavage in pulmonary alveolar proteinosis--a retrospective study.

Authors:  A Silva; A Moreto; C Pinho; A Magalhães; A Morais; C Fiuza
Journal:  Rev Port Pneumol       Date:  2014-07-18

Review 5.  Whole lung lavage-technical details, challenges and management of complications.

Authors:  Ahmed Awab; Muhammad S Khan; Houssein A Youness
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

6.  Efficacy of Whole-Lung Lavage in Pulmonary Alveolar Proteinosis: A Multicenter International Study of GELF.

Authors:  Pierre Gay; Benoit Wallaert; Stefan Nowak; Jonas Yserbyt; Stavros Anevlavis; Christophe Hermant; Alban Lovis; Olivier Menard; Bernard Maitre; Thomas Vandemoortele; Hervé Dutau; Amandine Briault; Arnaud Bourdin; Jean-Michel Vergnon; Marios E Froudarakis
Journal:  Respiration       Date:  2017-01-21       Impact factor: 3.580

7.  Bronchoscopic Lobar Lavage in the Treatment of a Single Lung Transplant Recipient With Pulmonary Alveolar Proteinosis: A Case Report.

Authors:  Phoebe Kahn; Markus Siegelin; Maggie Carroll; Frank D'ovidio; Selim Arcasoy
Journal:  Transplant Proc       Date:  2021-12-30       Impact factor: 1.066

8.  Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis.

Authors:  M Beccaria; M Luisetti; G Rodi; A Corsico; M C Zoia; S Colato; P Pochetti; A Braschi; E Pozzi; I Cerveri
Journal:  Eur Respir J       Date:  2004-04       Impact factor: 16.671

9.  Hemodynamic changes during whole bronchoalveolar lavage in two cases of pulmonary alveolar proteinosis.

Authors:  M A Aguinaga; P Santos; E Renes; P F Alvaro; J A Lorente; A Maudes; R R Diaz; L Landín; D Liste
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

10.  Combined-modality therapy for pulmonary alveolar proteinosis in a remote setting: a case report.

Authors:  Dacia S K Boyce; John W Lee; Phalgoon Shah; Judy H Freeman; Matthew C Aboudara; David C Hostler
Journal:  BMC Pulm Med       Date:  2019-03-12       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.